The end of the Public Health Emergency (PHE) for COVID-19 means more than just returning to business as usual for labs. Health plans are no longer required to reimburse labs for COVID-19 testing at 100% of billed charges, and as labs begin to see a reduction in reimbursements, payers should be keeping a keen eye on a new trend emerging across previously highly reimbursed codes approved by the Centers for Medicare & Medicaid Services. In a Managed Healthcare Executive article, Avalon EVP, Provider Networks, Mike Snyder details how Lab Benefit Managers are uniquely managing laboratory testing at scale.

Read more at Managed Healthcare Executive.